Please click here to contact our Investor Relations department.
There are currently no events scheduled.
LabCorp to Acquire Covance Conference Call
Nov. 3, 2014
LabCorp to Acquire Covance for Approximately $5.6 Billion, Creating World's Leading Healthcare Diagnostics Company
Nov. 03, 2014
Covance Reports Third Quarter Net Revenue Growth of 3.4% to $627 Million, Pro Forma EPS Growth of 18.2% to $0.98 and Adjusted Net Orders of $752 Million
Sep. 17, 2014
Covance and Fenova Research Establish Innovative Research Collaboration